Lucid Diagnostics Inc. (NASDAQ: LUCD) Stock Information | RedChip

Lucid Diagnostics Inc. (NASDAQ: LUCD) Listen to this Section


$0.82
-0.0145 ( -1.74% ) 69.6K

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Market Data


Open


$0.82

Previous close


$0.84

Volume


69.6K

Market cap


$41.20M

Day range


$0.82 - $0.89

52 week range


$0.63 - $1.72

Insider Ownership Transactions

Total Amount Purchased: -6,667,123.00 | $ -5,470,374.42

Date Type Amount Purchased Purchaser
2024-02-20 Sale -3331747.00 PAVmed Inc.
2024-01-30 Sale -3331771.00 PAVmed Inc.
2023-09-27 Sale -200.00 Lapidus Stanley
2023-09-22 Sale -3405.00 Lapidus Stanley

SEC Fillings


Form Type Description Pages Date
3 Insider transactions 1 May 09, 2024
4 Insider transactions 1 May 08, 2024
4 Insider transactions 1 May 08, 2024
4 Insider transactions 1 May 08, 2024
4 Insider transactions 1 May 08, 2024
8-k 8K-related 16 May 07, 2024
8-k 8K-related 14 May 02, 2024
def Proxies and info statements 3 Apr 29, 2024
ars Annual reports 1 Apr 29, 2024
pre Proxies and info statements 3 Apr 19, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.